The increasing prevalence of chronic diseases is anticipated to openup the new avenue for Compounding Chemotherapy Market
The Compounding Chemotherapy Market is estimated to be valued at US$ 10.20 Bn or Mn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.